fingolimod hydrochloride has been researched along with vitamin k 3 in 2 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (vitamin k 3) | Trials (vitamin k 3) | Recent Studies (post-2010) (vitamin k 3) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 1,316 | 10 | 504 |
| Protein | Taxonomy | fingolimod hydrochloride (IC50) | vitamin k 3 (IC50) |
|---|---|---|---|
| perilipin-5 | Homo sapiens (human) | 9.468 | |
| perilipin-1 | Homo sapiens (human) | 7.895 | |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | 8.6815 | |
| Aldehyde oxidase 1 | Mus musculus (house mouse) | 0.15 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 7.96 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 7.96 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 0.8925 | |
| Protein kinase C alpha type | Homo sapiens (human) | 2.2 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 3.02 | |
| Protein-glutamine gamma-glutamyltransferase 2 | Homo sapiens (human) | 2.2 | |
| M-phase inducer phosphatase 1 | Homo sapiens (human) | 4.55 | |
| M-phase inducer phosphatase 2 | Homo sapiens (human) | 3.16 | |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | 2.2 | |
| Aldehyde oxidase 1 | Oryctolagus cuniculus (rabbit) | 2 | |
| Aldehyde oxidase | Homo sapiens (human) | 0.2 | |
| Receptor-type tyrosine-protein phosphatase eta | Homo sapiens (human) | 2.2 | |
| Thiosulfate sulfurtransferase | Homo sapiens (human) | 1 | |
| Receptor protein-tyrosine kinase | Homo sapiens (human) | 2.2 | |
| 60 kDa chaperonin | Escherichia coli | 5.75 | |
| Aldehyde oxidase 1 | Macaca fascicularis (crab-eating macaque) | 0.11 | |
| 10 kDa chaperonin | Escherichia coli | 5.75 | |
| Aldehyde oxidase 1 | Rattus norvegicus (Norway rat) | 0.19 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boraldi, F; Fernandez, O; Garcia-Fernandez, M; Hurtado-Guerrero, I; Lara, E; Martín-Montañez, E; Oliver, B; Pavia, J; Valverde, N | 1 |
| Boraldi, F; Claros, S; Fernández, O; Garcia-Fernandez, M; Gil, A; Lara, E; Martín-Montañez, E; Pavia, J; Romero-Zerbo, SY; Valverde, N | 1 |
2 other study(ies) available for fingolimod hydrochloride and vitamin k 3
| Article | Year |
|---|---|
The S1P mimetic fingolimod phosphate regulates mitochondrial oxidative stress in neuronal cells.
Topics: Animals; Antioxidants; Cell Death; Cell Line; Dopaminergic Neurons; Fingolimod Hydrochloride; Humans; Lysophospholipids; Membrane Potential, Mitochondrial; Mice; Mitochondria; Molecular Mimicry; Multiple Sclerosis; Neuroprotection; Oxidative Stress; Oxygen Consumption; Phosphates; Reactive Oxygen Species; Sphingosine; Sphingosine-1-Phosphate Receptors; Vitamin K 3 | 2019 |
Neuronal Metabolism and Neuroprotection: Neuroprotective Effect of Fingolimod on Menadione-Induced Mitochondrial Damage.
Topics: Animals; Antioxidants; Cell Line; Fingolimod Hydrochloride; Glycolysis; Mice; Mitochondria; Neurodegenerative Diseases; Neurons; Neuroprotection; Neuroprotective Agents; Oxidative Stress; Sphingosine-1-Phosphate Receptors; Vitamin K 3 | 2020 |